| UHC Commercial Medical & Drug | Percutaneous Vertebroplasty and Kyphoplasty – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Proton Beam Radiation Therapy – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Radiation Therapy: Fractionation, Image-Guidance, and Special Services – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Ryplazim® (Plasminogen, Human-Tvmh) – Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Simponi Aria® (Golimumab) Injection for Intravenous Infusion – Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Surgery of the Hip – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Tocilizumab (Actemra®, Tofidence®, & Tyenne®) Injection for Intravenous Infusion – Commercial Medical Benefit Drug Policy | 2026-03-01 |
| UHC Commercial Medical & Drug | Treatment of Temporomandibular Joint Disorders – Commercial and Individual Exchange Medical Policy | 2026-03-01 |
| Paramount Healthcare | Molecular Diagnostic and Genetic Testing/
Genetic Counseling | 2026-03-01 |
| Paramount Healthcare | Gradient Compression Garments/Stockings | 2026-03-01 |